Ariane Thielens

512 total citations
7 papers, 408 citations indexed

About

Ariane Thielens is a scholar working on Immunology, Organic Chemistry and Molecular Biology. According to data from OpenAlex, Ariane Thielens has authored 7 papers receiving a total of 408 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 1 paper in Organic Chemistry and 1 paper in Molecular Biology. Recurrent topics in Ariane Thielens's work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). Ariane Thielens is often cited by papers focused on Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (3 papers) and Immunotherapy and Immune Responses (3 papers). Ariane Thielens collaborates with scholars based in France, United States and Germany. Ariane Thielens's co-authors include François Romagné, Éric Vivier, Nicolas Fuséri, Mathieu Bléry, Fabien Chanuc, Caroline Sola, Cécile Bonnafous, Holbrook E. Kohrt, Sophie Ugolini and Aurélien Marabelle and has published in prestigious journals such as Blood, Cancer Research and Current Opinion in Immunology.

In The Last Decade

Ariane Thielens

7 papers receiving 404 citations

Peers

Ariane Thielens

IMMUN

ONCOL

HEMAT

MB

PFM

Dave Ankarlo United States

P. S. A. Becker Germany

Juergen Kuball United States

Delphine Cendron France

Hongbo Wang United States

Dixie Lewis United States

Rimke Oostvogels Netherlands

F Triebel France

Elshafa H. Ahmed United States

Akiko Iguchi‐Manaka Japan

Dave Ankarlo United States

Ariane Thielens

427 ×1.1

IMMUN

226 ×0.9

ONCOL

47 ×0.9

HEMAT

63 ×2.0

MB

18 ×0.8

PFM

Citations per year, relative to Ariane Thielens Ariane Thielens (= 1×) peers Dave Ankarlo

Countries citing papers authored by Ariane Thielens

Since Specialization

Citations

This map shows the geographic impact of Ariane Thielens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariane Thielens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariane Thielens more than expected).

Fields of papers citing papers by Ariane Thielens

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariane Thielens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariane Thielens. The network helps show where Ariane Thielens may publish in the future.

Co-authorship network of co-authors of Ariane Thielens

This figure shows the co-authorship network connecting the top 25 collaborators of Ariane Thielens. A scholar is included among the top collaborators of Ariane Thielens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariane Thielens. Ariane Thielens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Bléry, Mathieu, Cécile Bonnafous, Valentine Péri, et al.. (2014). Abstract 5037: Targeting MICA with therapeutic antibodies for the treatment of cancer. Cancer Research. 74(19_Supplement). 5037–5037. 1 indexed citations

2.

Kohrt, Holbrook E., Ariane Thielens, Aurélien Marabelle, et al.. (2013). Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies. Blood. 123(5). 678–686. 229 indexed citations

3.

Sola, Caroline, Fabien Chanuc, Ariane Thielens, et al.. (2013). Abstract 493: Antitumoral efficacy of therapeutic human anti-KIR antibody (BMS-986015/IPH2102) in a preclinical xenograft tumor model.. Cancer Research. 73(8_Supplement). 493–493. 1 indexed citations

4.

Bonnafous, Cécile, Valentine Péri, Sylvia Trichard, et al.. (2013). Targeting MICA with therapeutic antibodies for the treatment of cancer. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P41–P41. 4 indexed citations

5.

Kohrt, Holbrook E., Ariane Thielens, Aurélien Marabelle, et al.. (2013). Anti-KIR Antibody Enhancement Of Anti-Lymphoma Activity Of Natural Killer Cells As Monotherapy and In Combination With Anti-CD20 Antibodies. Blood. 122(21). 4417–4417. 12 indexed citations

6.

Sola, Caroline, Fabien Chanuc, Ariane Thielens, et al.. (2013). Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model. Journal for ImmunoTherapy of Cancer. 1(Suppl 1). P40–P40. 6 indexed citations

7.

Thielens, Ariane, Éric Vivier, & François Romagné. (2012). NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Current Opinion in Immunology. 24(2). 239–245. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact